Abstract
Helicobacter pylori pathogenic action involves the colonization of the gastrointestinal tract and a large production of reactive oxygen species (ROS) by the neutrophils attracted to the site of infection. The aim of this study was to evaluate caffeic acid and its alkyl esters as inhibitors of the release of ROS by Helicobacter pylori activated neutrophils and their bactericidal effect. The increased hydrophobicity caused by esterification had direct consequence in their efficiency as bactericidal agents against H. pylori and inhibitors of the production of ROS by neutrophils. The minimum inhibitory concentration (MIC) decreased from higher than 1000 μg/mL (caffeic acid) to 250 μg/mL to butyl and heptyl caffeate. The release of total ROS, superoxide anion and hypochlorous acid by activated neutrophils was also significantly decreased and the esters were more efficient than the acid precursor. In conclusion, the alkyl esters of caffeic acid have two properties that are complementary for the treatment of H. pylori infections: bactericidal activity and inhibitory effect upon generation of ROS by neutrophils. Hence, we propose that these easily synthesized and non-expensive substances should be applied to in vivo experimental models of H. pylori induced gastric infections.
Keywords: Alkyl caffeates, caffeic acid, helicobacter pylori, hypochlorous acid, myeloperoxidase, NADPH-oxidase.
Medicinal Chemistry
Title:Alkyl Caffeates as Anti-Helicobacter Pylori and Scavenger of Oxidants Produced by Neutrophils
Volume: 10 Issue: 1
Author(s): Luana Chiquetto Paracatu, Cibele Bonacorsi, Carolina Maria Quinello Gomes de Farias, Ana Carolina Nazaré, Maicon Segalla Petrônio, Luiz Octávio Regasini, Dulce Helena Siqueira Silva, Maria Stella Gonçalves Raddi, Luiz Marcos da Fonseca and Valdecir Farias Ximenes
Affiliation:
Keywords: Alkyl caffeates, caffeic acid, helicobacter pylori, hypochlorous acid, myeloperoxidase, NADPH-oxidase.
Abstract: Helicobacter pylori pathogenic action involves the colonization of the gastrointestinal tract and a large production of reactive oxygen species (ROS) by the neutrophils attracted to the site of infection. The aim of this study was to evaluate caffeic acid and its alkyl esters as inhibitors of the release of ROS by Helicobacter pylori activated neutrophils and their bactericidal effect. The increased hydrophobicity caused by esterification had direct consequence in their efficiency as bactericidal agents against H. pylori and inhibitors of the production of ROS by neutrophils. The minimum inhibitory concentration (MIC) decreased from higher than 1000 μg/mL (caffeic acid) to 250 μg/mL to butyl and heptyl caffeate. The release of total ROS, superoxide anion and hypochlorous acid by activated neutrophils was also significantly decreased and the esters were more efficient than the acid precursor. In conclusion, the alkyl esters of caffeic acid have two properties that are complementary for the treatment of H. pylori infections: bactericidal activity and inhibitory effect upon generation of ROS by neutrophils. Hence, we propose that these easily synthesized and non-expensive substances should be applied to in vivo experimental models of H. pylori induced gastric infections.
Export Options
About this article
Cite this article as:
Paracatu Chiquetto Luana, Bonacorsi Cibele, Quinello Gomes de Farias Maria Carolina, Nazaré Carolina Ana, Petrônio Segalla Maicon, Regasini Octávio Luiz, Siqueira Silva Helena Dulce, Gonçalves Raddi Stella Maria, da Fonseca Marcos Luiz and Ximenes Farias Valdecir, Alkyl Caffeates as Anti-Helicobacter Pylori and Scavenger of Oxidants Produced by Neutrophils, Medicinal Chemistry 2014; 10 (1) . https://dx.doi.org/10.2174/157340641001131226125042
DOI https://dx.doi.org/10.2174/157340641001131226125042 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Growth of Chlorella vulgaris in High Concentrations of Nitrate and Nitrite for Wastewater Treatment
Current Biotechnology Antibody-Drug Conjugate Targets
Current Cancer Drug Targets The Adrenergic System in Gastrointestinal Cancers
Current Cancer Therapy Reviews Cancer Microbiome; Opportunities and Challenges
Endocrine, Metabolic & Immune Disorders - Drug Targets Therapeutical Approaches of Vasoactive Intestinal Peptide as a Pleiotropic Immunomodulator
Current Pharmaceutical Design Clinical Pharmacogenetics in Oncology: the Paradigm of Molecular Targeted Therapies
Current Pharmaceutical Design Voltage-Dependent Potassium Channels Kv1.3 and Kv1.5 in Human Cancer
Current Cancer Drug Targets Aspartic Proteinases in Disease: A Structural Perspective
Current Drug Targets Measurement of CYP1A2 Activity: A Focus on Caffeine as a Probe
Current Drug Metabolism Targeted Multifunctional Lipid-Based Nanocarriers for Image-Guided Drug Delivery
Anti-Cancer Agents in Medicinal Chemistry Role of Sulforaphane in Protection of Gastrointestinal Tract Against H. pylori and NSAID-Induced Oxidative Stress
Current Pharmaceutical Design A Comprehensive Review on SAR of Curcumin
Mini-Reviews in Medicinal Chemistry An Overview of Phytotherapeutic Approaches for the Treatment of Tuberculosis
Mini-Reviews in Medicinal Chemistry Enhancing the Site-Specific Targeting of Macromolecular Anticancer Drug Delivery Systems
Current Drug Targets The Co-regulatory Role of 5-Lipoxygenase and Cyclooxygenase-2 in the Carcinogenesis and their Promotion by Cigarette Smoking in Colons
Current Medicinal Chemistry Curcumin as an Anti-Cancer Agent: Review of the Gap Between Basic and Clinical Applications
Current Medicinal Chemistry Herbal Insomnia Medications that Target GABAergic Systems: A Review of the Psychopharmacological Evidence
Current Neuropharmacology Anticancer Activity of an Oplopanax elatus Stem Extract and Biologically Active Isolated Compounds
Current Pharmaceutical Biotechnology An Update on Hepatic Stem Cells: Bench to Bedside
Current Pharmaceutical Biotechnology Simple C-2-Substituted Quinolines and their Anticancer Activity
Letters in Drug Design & Discovery